Acro Biomedical (ACBM) Cash from Operations Growth (3y) (2018 - 2025)
Powered by 
Analysis
Acro Biomedical (ACBM) Cash from Operations Growth (3y) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 11.28% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | -2.49% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 4.88% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 16.01% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -37.63% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | -10.65% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -33.91% |
| Sep 30, 2025 | -0.71% |
| Jun 30, 2025 | 35.22% |
| Mar 31, 2025 | -27.77% |
| Dec 31, 2024 | 44.20% |
| Sep 30, 2024 | 53.87% |
| Jun 30, 2024 | -26.30% |
| Mar 31, 2024 | -17.27% |
| Sep 30, 2023 | 26.15% |
| Jun 30, 2023 | 26.65% |
| Mar 31, 2023 | 40.19% |
| Dec 31, 2022 | -32.05% |
| Sep 30, 2022 | 17.43% |
| Jun 30, 2022 | -35.98% |
| Mar 31, 2022 | 91.37% |
| Dec 31, 2021 | -32.90% |
| Sep 30, 2021 | -149.28% |
| Jun 30, 2021 | 41.69% |
| Mar 31, 2021 | -26.42% |
| Sep 30, 2020 | 46.26% |